Published in Journal of Experimental Medicine · View the paper (DOI)
CAR T cells kill cancer cells directly, rather than relying on other immune cells. Reducing encounters with circulating B cells can enhance CAR T cell infiltration and persistence, improving treatment outcomes.
Coverage from 2 institutions